Replication of live attenuated cold-adapted H2N2 influenza virus vaccine candidates in non human primates

The development of an H2N2 vaccine is a priority in pandemic preparedness planning. We previously showed that a single dose of a cold-adapted (ca) H2N2 live attenuated influenza vaccine (LAIV) based on the influenza A/Ann Arbor/6/60 (AA ca) virus was immunogenic and efficacious in mice and ferrets....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Vaccine
Autors principals: Broadbent, Andrew J., Santos, Celia P., Paskel, Myeisha, Matsuoka, Yumiko, Lu, Janine, Chen, Zhongying, Jin, Hong, Subbarao, Kanta
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4259263/
https://ncbi.nlm.nih.gov/pubmed/25444799
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2014.10.065
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars